Cargando…

Experimental Models of Type-2 Diabetic Nephropathy

Detalles Bibliográficos
Autores principales:	Tomino, Yasuhiko, Cooper, Mark E., Kurtz, Theodore W., Shimizu, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313567/ https://www.ncbi.nlm.nih.gov/pubmed/22474417 http://dx.doi.org/10.1155/2012/218917

Ejemplares similares

Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic Nephropathy
por: Tomino, Yasuhiko
Publicado: (2012)

Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
por: Furukawa, Masako, et al.
Publicado: (2013)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Role of Mindin in Diabetic Nephropathy
por: Murakoshi, Maki, et al.
Publicado: (2011)

Diagnosis and treatment of patients with IgA nephropathy in Japan
por: Tomino, Yasuhiko
Publicado: (2016)

New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy
por: Soler, María José, et al.
Publicado: (2012)

Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?
por: Park, Cheol Whee
Publicado: (2013)

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
por: Ohsawa, Isao, et al.
Publicado: (2012)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Revisiting Experimental Models of Diabetic Nephropathy
por: Giralt-López, Anna, et al.
Publicado: (2020)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
por: Lavoz, Carolina, et al.
Publicado: (2020)

Pathogenesis of diabetic nephropathy
por: Cao, Zemin, et al.
Publicado: (2011)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

A glimpse of diabetic nephropathy
por: Khoshjou, Farhad
Publicado: (2016)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

Rodent models of diabetic nephropathy: their utility and limitations
por: Kitada, Munehiro, et al.
Publicado: (2016)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

Post-Operative Kidney Function Using Deep Hypothermic Circulatory Arrest (DHCA) in Aortic Arch Operation
por: Higo, Masahide, et al.
Publicado: (2022)

Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
por: Kang, Shin-Wook
Publicado: (2012)

Diabetic Nephropathy: From Pathophysiology to Treatment
por: Shen, Ziyan, et al.
Publicado: (2017)

Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm
por: Goto, Masashi, et al.
Publicado: (2009)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Preventive effect of taurine on experimental type II diabetic nephropathy
por: Lin, Shumei, et al.
Publicado: (2010)

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
por: Fukami, Kei, et al.
Publicado: (2014)

Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy
por: Maiguma, Masayuki, et al.
Publicado: (2014)

Experimental model of nephropathy associated with diabetes mellitus in mice
por: Silva, Pâmela Henrique, et al.
Publicado: (2023)

MPGN Type 3 Associated with Pemphigus Herpetiformis Mimicking PGNMID and Dermatitis Herpetiformis
por: Shimizu, Yoshio, et al.
Publicado: (2019)

Combat Diabetic Nephropathy: From Pathogenesis to Treatment
por: Gohda, Tomohito, et al.
Publicado: (2014)

MicroRNAs for podocyte injury in diabetic nephropathy
por: Morishita, Yoshiyuki
Publicado: (2021)

Vitamin D in diabetic nephropathy
por: Prabhu, RA, et al.
Publicado: (2018)

Progressive Renal Dysfunction due to IgG4-Related Kidney Disease Refractory to Steroid Therapy: A Case Report
por: Wakabayashi, Keiichi, et al.
Publicado: (2019)

The Influence of an Unexpected Switch of Hemodialysis Facilities on the Quality of Life (QOL) in Hemodialysis Patients
por: Shimizu, Yoshio, et al.
Publicado: (2022)

Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy
por: Kajiyama, Tadahiro, et al.
Publicado: (2011)

A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study
por: Goto, Masashi, et al.
Publicado: (2009)

A Case of Arteriovenous Fistula after Renal Biopsy in an IgA Nephropathy Patient with Macroscopic Hematuria
por: Horikoshi, Satoshi, et al.
Publicado: (2013)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

Biomarkers of progression in diabetic nephropathy: The past, present and future
por: Lee, Chi-Ho, et al.
Publicado: (2015)

Where do we stand on human diabetic nephropathy?
por: Ryong Cha, Dae
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jci7r7ohsm8hno8gnhtfjm2dfl